ClinicalTrials.gg
RecruitingNCT06992752Updated May 28, 2025

Dysfunctional Breathing in Individuals With Thoracic Outlet Syndrome

An observational study in Thoracic Outlet Syndrome, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Feb 2025; still recruiting 1 year 9 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
54
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this observational study was to learn about the characteristics of dysfunctional breathing in individuals with thoracic outlet syndrome. The main question to be answered is:

Is there a dysfunctional breathing pattern in individuals with Thoracic outlet syndrome? These features will be compared with a healthy control group to evaluate the association of Thoracic outlet syndrome with dysfunctional breathing

02

Conditions studied

  • Thoracic Outlet Syndrome

Keywords

  • Thoracic Outlet Syndrome
  • Dysfunctional Breathing
03

In context

Thoracic Outlet Syndrome

33 studies on the registry are indexed under Thoracic Outlet Syndrome; 11 are open to participants now.

This study's planned enrollment of 54 is below the median of 84 across 16 observational studies indexed under Thoracic Outlet Syndrome.

Browse Thoracic Outlet Syndrome studies →

Lead sponsor

Hacettepe University is the lead sponsor of 1,007 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

In the study, adult patients aged between 18-65 years who were diagnosed with TOS by a thoracic surgeon at the Cardiopulmonary Rehabilitation Unit of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, and who had pain complaints for more than 6 months without surgery will be evaluated. Control cases planned to be included in the study to compare with the results of the patients will be formed by using the snowball method from the immediate environment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To agree to participate in the study,
  • To have been diagnosed with TOS by a thoracic surgeon,
  • To be between 18-65 years old,
  • Having pain for more than 6 months

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of spinal or thoracic surgery for TOS or any other reason,
  • People with traumatic cervical injury,
  • Severely obese people ( >40 kg/m2),
  • People with clinical abnormalities in the thoracic cage or vertebral column,
  • Persons with occupational industrial exposures,
  • Patients with severe comorbidities (neurological, neuromuscular, -cardiorespiratory, psychiatric and musculoskeletal) diabetes mellitus and/or
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
54 participants (estimated)
Patient registry
No

Groups and cohorts

  • Thoracic Outlet Syndrome

    Thoracic Outlet Syndrome

  • Healthy control

    Healthy control

06

What researchers measure

Primary outcomes

  1. Nijmegen Questionnaire

    A cut-off score of ≥20 in Nijmegen will be used to define dysfunctional breathing. The minimum score is 0 and the maximum score is 60 points. Higher scores mean worse outcome.

    Time frame: Day 1

  2. End tidal CO2

    A standard value of \<35 mmHg will be used as the cut-off point for dysfunction

    Time frame: Day 1

  3. Manual Assessment of Respiratory Motion

    This technique is used to assess and measure the distribution of respiratory movement between the upper and lower parts of the rib cage and abdomen

    Time frame: 5 minutes

Secondary outcomes

  1. Forced Vital Capacity (FVC)

    Forced Vital Capacity (FVC) will be done with a spirometer according to the American Thoracic Society and European Respiratory Society criteria. The total amount of air (L) that can be forced out after taking a deep breath will be recorded. Measures lung capacity.

    Time frame: Day 1

  2. Forced Expiratory Volume in 1 second (FEV1)

    Forced Expiratory Volume in 1 second (FEV1) will be done with a spirometer according to the American Thoracic Society and European Respiratory Society criteria. The amount of air (L) a person can forcefully expel in the first second of a breath will be recorded

    Time frame: Day 1

  3. FEV1/FVC Ratio

    The percentage of the ratio of FEV1 to FVC will be calculated and recorded

    Time frame: Day 1

  4. Forced Expiratory Flow 25-75% (FEF25-75)

    Forced Expiratory Flow 25-75% (FEF25-75%) will be assessed with a spirometer according to American Thoracic Society and European Respiratory Society criteria. The air flow rate (L/s) during the middle part of the exhalation (25%-75%) will be recorded.

    Time frame: Day 1

  5. Peak Expiratory Flow (PEF)

    Peak Expiratory Flow (PEF) will be assessed with a spirometer according to American Thoracic Society and European Respiratory Society criteria. The highest flow rate (L/s) achieved during a forceful exhalation will be recorded.

    Time frame: Day 1

  6. Breath Holding at Functional Residual Capasity

    If the duration is less than 25 seconds, it is considered as possible dysfunctional breathing

    Time frame: 5 minutes

  7. Breath Holding at Total Lung Capacity

    If the duration is less than 35 seconds, it is considered as possible dysfunctional breathing

    Time frame: 5 minutes

  8. Pain severity

    Visual analog scale (VAS) will be used in the assessment.Individuals' pain at rest, during activity and at night will be assessed on a scale of 0-10.Minimum score is 0 and maximum score is 10 Higher scores mean a worse outcome.

    Time frame: 5 minutes

  9. Pain treshold

    For the assessment of pain threshold, the minimum pressure value that causes pain or discomfort will be recorded

    Time frame: 10 minutes

  10. Pain tolerance

    the maximum tolerated pressure value will be recorded in the assessment of pain tolerance

    Time frame: 10 minutes

  11. Beck Anxiety Scale

    The scale has 21 questions. The questions will be answered by selecting one of four options: none, mild, moderate and severe. 8-15 points will be categorized as mild anxiety symptoms, 16-25 points as moderate anxiety symptoms, 26 - 63 points as severe anxiety symptoms. the maximum score of the scale is 63

    Time frame: 5 minutes

  12. EQ-5D-5L General Quality of Life Scale

    The scale has two parts. The first section has five sub-scales: movement, self-care, usual activities, pain/discomfort and anxiety/depression. The answers given in each section have 5 options; "no problem", "mild problem", "moderate problem", "severe problem" and "extreme problem". In the second section, individuals give a value between 0 and 100 about their current health status.

    Time frame: 5 minutes

  13. Type D Personality Scale

    It consists of a total of 14 items and two subscales measuring negative affectivity and social inhibition. Each item is scored on a 0-4 scale. The cut-off point of the two subscales is ≥ 10.

    Time frame: 5 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — for patient data privacy

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2025 (actual). Primary completion is estimated for Sep 2025, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2025
First posted
May 28, 2025
StartActual
Feb 2, 2025
Primary completionEst.
Sep 2, 2025
CompletionEst.
Oct 2, 2025
Last update
May 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06992752
Responsible party
Melda Saglam (Professor, Hacettepe University) — Principal investigator
First posted
May 28, 2025
Start date
Feb 2, 2025
Primary completion
Sep 2, 2025 (estimated)
Completion
Oct 2, 2025 (estimated)
Last update
May 28, 2025

Study contacts

Melda Sağlam, Professor
Contact
msaglam@hacettepe.edu.tr
+903123052525 ext. 146
Melda Sağlam, Professor
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion